SCHEMBL7465304

SCHEMBL7465304

CCc1cccc(C=C2SC(=O)NC2=O)c1

nearest known ligand 0.73

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
PIM1 P11309 10/20 0.73
PIM2 Q9P1W9 10/20 0.73
IGF1R P08069 2/20 0.73
AKR1B1 P15121 4/20 0.63
CISD1 Q9NZ45 4/20 0.63
MAOA P21397 1/20 0.63
MAOB P27338 1/20 0.63
GSK3B P49841 1/20 0.63
PIM3 Q86V86 1/20 0.62
TTR P02766 1/20 0.59
NPC1 O15118 1/20 0.58
RAB9A P51151 1/20 0.58
MYC P01106 1/20 0.58
MAX P61244 1/20 0.58
HPGD P15428 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7465302 1.00 PIM1 (0.73) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL17147367 0.86 HPGD (0.73) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539573 0.85 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539569 0.85 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539566 0.85 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL7465312 0.83 CSNK2A2 (0.51) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539676 0.81 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539679 0.81 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL2539680 0.81 PIM1 (1.00) PIM1PIM2IGF1RAKR1B1CISD1
SCHEMBL1581116 0.80 MAOA (0.59) PIM1PIM2IGF1RAKR1B1CISD1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1214305-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION Maxia Pharmaceuticals, Inc. (US) 2002-06-19 EP claimed
WO-2001016123-A1 BENZYLIDENE-THIAZOLIDINEDIONES AND ANALOGUES AND THEIR USE IN THE TREATMENT OF INFLAMMATION MAXIA PHARMACEUTICALS, INC. (US) 2001-03-08 WO claimed